MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Receives RMAT For LVAD Heart Failure Patients, page-104

  1. 308 Posts.
    lightbulb Created with Sketch. 159
    Can we infer any impact on MSB-MNK deal from the MNK bid to acquire sucampo?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.